de-104
Small moleculeexperimental
USS Breeman (DE-104) was a Cannon class destroyer escort in service with the United States Navy from 1943 to 1946. In 1948, she was sold to Taiwan, where she served as Taihu (太湖) until 1972. — Wikipedia
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
4
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2008 (NCT00650338)
Timeline
Indications
Mechanism of action
- Rho-associated protein kinaseINHIBITOR
Rho-associated protein kinase inhibitor
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaUSS Breeman ↗
- ChEMBLCHEMBL3545153 ↗
Also known as
- de-104
- de-104
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00868894 | Phase 1/Phase 2 (Phase 2) | Mar 1, 2009 | Santen Inc. |
| NCT00656240 | Phase 2 | Apr 7, 2008 | Santen Inc. |
| NCT00657579 | Phase 2 | Apr 7, 2008 | Santen Inc. |
| NCT00650338 | Phase 2 | Mar 1, 2008 | Santen Inc. |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Santen Inc. | For profit | 4 | 4 | 1 | 2008 |
1 organizations
Page 1 / 1